Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
DCOY
DCOY
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
DCOY News
Decoy Therapeutics Launches Multi-Virus Antiviral Platform
Apr 09 2026
PRnewswire
Decoy Therapeutics Launches Multi-Viral Antiviral Platform
Apr 09 2026
Newsfilter
Decoy Therapeutics CEO to Participate in Investor Event
Apr 06 2026
PRnewswire
Decoy Therapeutics CEO to Participate in Investor Event
Apr 06 2026
Newsfilter
Decoy Partners with Quantori to Enhance Antiviral Drug Design Capacity
Mar 11 2026
PRnewswire
Decoy Partners with Quantori to Enhance Antiviral Drug Design Capacity
Mar 11 2026
Newsfilter
Decoy Therapeutics to Execute 1-for-12 Reverse Stock Split
Mar 05 2026
seekingalpha
Decoy Therapeutics Announces 1-for-12 Reverse Stock Split
Mar 05 2026
PRnewswire
Decoy Therapeutics to Participate in Corporate Connect Webinar
Feb 05 2026
PRnewswire
Decoy Therapeutics Partners with Gates Foundation on Global Access Commitment
Feb 04 2026
PRnewswire
Decoy Therapeutics Announces Global Access Commitment with Gates Foundation
Feb 04 2026
Newsfilter
Roth Capital Initiates Buy Rating on vTv Therapeutics with $58 Price Target
Jan 23 2026
Benzinga
Decoy Therapeutics Secures Gates Foundation Funding to Advance Global Manufacturing of Antivirals
Jan 13 2026
PRnewswire
Show More News
